Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
tc
10x genomics
astellas pharma
becton dickinson
biotech
cancer
cancer diagnostics
cancer screening
color genomics
deals
diagnostic device
fundings & exits
genetic testing
genetics
genomic medicine
genomic testing
genomics
health
idiopathic pulmonary fibrosis (ipf)
life sciences
lucence diagnostics
lung cancer
lymphoma
medical
medical device
medicine
merck
nanostring
national blog main
new york blog main
raleigh-durham blog main
san diego blog main
san francisco
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
singapore
startups
veracyte
What
technology
3
×
tests
3
×
company
diagnostics
participants
adding
aims
alphabet’s
analysis
announced
baseline
business
cancer
color
companies
company’s
deal
decisions
develops
diagnostic
emphasis
expand
focused
fold
genetic
genetics
genomic
genomics
google
groups
health
healthcare
help
ihh
included
information
integrated
invasive
largest
led
Language
unset
3
×
Current search:
tests
×
technology
×
unset
×
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@techcrunch.com
4 years ago
Lucence raises $20 million Series A for its non-invasive cancer screening technology
@techcrunch.com
4 years ago
Verily, Alphabet’s other money-making, non-Google business, partners with Color on genetic analysis
